Global Radiotherapy-Induced Nausea and Vomiting Treatment Market Analysis By Treatment Type (Prophylactic Treatment, Rescue Treatment), By Drug Class (5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids, Benzodiazepines), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Patient Demographics (Adults, Pediatrics), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: June 2024
- Report ID: 84417
- Number of Pages: 301
- Format:
-
-
-
- Heron Therapeutics Inc.
- TESARO (a GSK company)
- Helsinn Healthcare SA
- Merck & Co. Inc.
- Amgen Inc.
- Fresenius Kabi AG
- Mylan N.V.
- Baxter International Inc.
- Kyowa Kirin Co. Ltd.
- CinnaGen Co.
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible